Fertility challenges affect a significant number of couples in Kenya — research suggests that approximately one in three Kenyan couples struggles with infertility, with rates estimated at 30–40%. Among gynaecology consultations, subfertility accounts for 26.1% of cases, with tubal factors responsible for 50% and male factors for 15%. In a society where procreation is often considered mandatory rather than optional, childless individuals frequently face stigma, isolation, and ostracism, and most women pursuing fertility treatment choose not to disclose it due to social pressure. Despite these challenges, Kenya has made significant strides: the country's first IVF baby has already turned 18, and the ART Bill 2022, passed by the National Assembly, established Kenya's first legal framework for assisted reproduction, creating an ART Directorate responsible for licensing, inspection, and maintaining national registers. This guide covers the key fertility tests available for both men and women in Kenya and what you can expect at each step.
When Should You Consider Fertility Testing?
Medical professionals generally recommend fertility testing under the following circumstances:
- Women under 35 who have been trying to conceive for 12 months or more without success
- Women 35 and older who have been trying for 6 months or more
- Women with irregular menstrual cycles, painful periods, or a history of pelvic inflammatory disease — particularly relevant in Kenya, where evidence of past pelvic inflammatory disease is found in over 80% of infertility cases
- Men with known risk factors such as a history of testicular injury, undescended testes, or prior surgeries in the groin area
- Couples with a history of recurrent miscarriages (two or more consecutive pregnancy losses)
- Anyone with a known medical condition that may affect fertility, such as polycystic ovary syndrome (PCOS), endometriosis, or thyroid disorders
Fertility is not solely a woman's issue. Approximately 40% of infertility cases involve male factors, making it essential for both partners to be evaluated. In sub-Saharan Africa, untreated STIs cause up to 85% of infertility among women seeking care, and schistosomiasis is an additional infertility risk factor in East Africa.
Fertility Tests for Women
Hormone Panel Testing
Hormonal imbalances are one of the most common causes of female infertility. A comprehensive hormone panel typically includes:
- FSH (Follicle Stimulating Hormone) – Tested on day 2-3 of the menstrual cycle to assess ovarian reserve. Elevated FSH may indicate reduced egg supply.
- LH (Luteinizing Hormone) – Works alongside FSH in regulating the menstrual cycle and ovulation. An abnormal LH-to-FSH ratio can indicate PCOS.
- Estradiol (E2) – Tested alongside FSH on cycle day 2-3. Elevated estradiol with normal FSH may mask a diminished ovarian reserve.
- AMH (Anti-Mullerian Hormone) – One of the most reliable markers of ovarian reserve. Unlike other hormones, AMH can be tested at any time during the menstrual cycle.
- Progesterone – Tested approximately 7 days after expected ovulation (usually day 21 of a 28-day cycle) to confirm whether ovulation has occurred.
- Prolactin – Elevated prolactin levels can interfere with ovulation.
- Thyroid Hormones (TSH, Free T4) – Both hypothyroidism and hyperthyroidism can affect fertility and increase the risk of miscarriage.
Ovarian Reserve Testing
Ovarian reserve refers to the quantity and quality of a woman's remaining eggs. In addition to the AMH and FSH tests mentioned above, an antral follicle count (AFC) performed via transvaginal ultrasound provides valuable information about the number of follicles available for potential ovulation.
Additional Female Fertility Tests
- Hysterosalpingography (HSG) – An X-ray procedure that evaluates whether the fallopian tubes are open and the uterine cavity is normal.
- Pelvic Ultrasound – Assesses the uterus and ovaries for structural abnormalities such as fibroids, polyps, or ovarian cysts.
- Rubella and Varicella Immunity – Important to confirm immunity before conception, as these infections can harm the developing foetus.
Fertility Tests for Men
Semen Analysis
A semen analysis is the cornerstone of male fertility evaluation. It assesses several key parameters:
- Sperm Count – A normal count is 15 million or more sperm per millilitre of semen. Below this threshold is considered oligozoospermia.
- Motility – At least 40% of sperm should be motile (moving). Progressive motility, where sperm swim forward in a straight line, is particularly important.
- Morphology – The shape and structure of sperm. At least 4% of sperm should have normal morphology according to WHO criteria.
- Volume – Normal semen volume is 1.5 millilitres or more per ejaculation.
- pH and Liquefaction – Abnormal pH or failure to liquefy within 60 minutes may indicate prostate or seminal vesicle issues.
For accurate results, men are typically advised to abstain from ejaculation for 2-5 days before the test. The sample should be collected at the laboratory or delivered within 30-60 minutes of collection.
Male Hormone Testing
If the semen analysis reveals abnormalities, hormonal evaluation may be recommended. This includes:
- Testosterone – Low testosterone can affect sperm production.
- FSH and LH – Help identify whether the issue lies in the testes themselves or in the hormonal signals from the brain.
- Prolactin – Elevated prolactin in men can reduce sperm production and libido.
How to Prepare for Fertility Testing
Proper preparation ensures the most accurate results:
- For women: Note the first day of your last menstrual period, as many hormone tests are cycle-dependent.
- For men: Observe the recommended abstinence period of 2-5 days before semen analysis.
- Both partners: Bring a list of any medications, supplements, or herbal remedies you are taking, as some can affect test results.
- Bring previous medical records if you have been treated for any reproductive conditions.
- Blood tests: Fasting is generally not required for hormone tests, but check with your healthcare provider.
Fertility Testing and Treatment Costs in Kenya
Understanding the financial commitment involved in fertility care is important for planning. Typical costs in Nairobi include:
- Initial consultation: KES 3,000–5,000
- Comprehensive fertility workup (both partners): KES 30,000–45,000
- Hormonal tests (female): KES 18,000–33,000
- Pelvic ultrasound: KES 3,000
- Standard IVF cycle: KES 400,000–700,000
It is important to note that fertility treatments are generally not covered by insurance in Kenya. Couples should plan their finances accordingly and discuss payment options with their chosen clinic.
Understanding Your Fertility Test Results
Fertility test results should always be interpreted by a qualified medical professional within the context of your overall health, age, and reproductive history. A single abnormal result does not necessarily mean you cannot conceive. Many conditions identified through testing are treatable, and our medical team can guide you through the next steps, which may include lifestyle modifications, medication, or referral to a fertility specialist.
Fertility Testing at CA Medlynks
CA Medlynks offers comprehensive fertility testing services for both men and women in a comfortable, confidential setting. Our KENAS-accredited laboratory provides accurate results for all hormone panels, semen analysis, and related diagnostic tests. We work closely with fertility specialists across Nairobi — including established hubs such as Nairobi IVF Centre, Footsteps to Fertility Centre, and Harley Street Fertility Centre — to ensure you receive coordinated care throughout your journey.
All our fertility packages include a doctor consultation to review your results and discuss next steps. At many labs, you receive results without professional interpretation, but at CA Medlynks your package price covers the consultation (normally KES 4,000 separately), so there are no surprise costs after testing.
Taking the first step can be the hardest, but knowledge is empowering. Contact us today to schedule your fertility evaluation and take control of your family planning future.